(Q41715923)

7 October 2017

title

Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score (English)

1 reference

7 October 2017

main subject

hepatocellular carcinoma

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hae-Ryong Yun

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Kwang-Hyub Han

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

3

Beom Kyung Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1

Yehyun Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Seung Up Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jun Yong Park

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Do Young Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yong Eun Park

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ji Hye Park

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yong Il Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

25 May 2015

1 reference

7 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

100-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of viral hepatitis and hepatocellular carcinoma

12 June 2020

cites work

1 reference

21 January 2018

Global cancer statistics

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma

21 January 2018

1 reference

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization

21 January 2018

1 reference

Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.

21 January 2018

1 reference

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

21 January 2018

1 reference

Validation of the hepatoma arterial embolization prognostic score in European and Asian populations and proposed modification

21 January 2018

1 reference

[Practice guidelines for management of hepatocellular carcinoma 2009].

21 January 2018

1 reference

LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.

21 January 2018

1 reference

Current strategy for staging and treatment: the BCLC update and future prospects.

21 January 2018

1 reference

Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation

21 January 2018

1 reference

Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization.

21 January 2018

1 reference

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide

21 January 2018

1 reference

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma.

21 January 2018

1 reference

The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE.

21 January 2018

1 reference

Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26013186%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference